①Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
Azegami T, Yuki Y, Nakahashi R, Itoh H, Kiyono H.
Mol Immunol. 2017 Oct 30. pii: S0161-5890(17)30551-5.
doi:10.1016/j.molimm.2017.10.022. [Epub ahead of print]
②Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
Nakahashi-Ouchida R, Yuki Y, Kiyono H.
Expert Rev Vaccines. 2017 Oct 27:1-10.
doi: 10.1080/14760584.2017.1395702. [Epub ahead of print]
You are invited to meet with our speaker at the following meetings
June 23, Fri
RIKEN IMS-JSI International Symposium on Immunology, “Mucosal Trio-regulatory Machinery of Epithelial Cells-Innate Lymphoid Cells-Commensal Bacteria for Gut Homeostasis and Inflammation,” Dr. Kiyono as Invited Speaker, Tokyo, Japan
ISV Congress 2017, Dr. Kiyono as Invited Speaker, Paris, France
Oct 19, 2017
La Jolla Immunology Conference, Session on Immunity at Mucosal Barriers, Dr. Kiyono as Invited Speaker, CA, USA